
Capsida Biotherapeutics granted orphan drug designation for potential gene therapy for STXBP1-related disorders

FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy

Advancing Toward Gene Therapies for Rare Epilepsies

Newly Published “Voice of the Patient Report”

STXBP1 Census - Q3 2024

Six patient advocacy groups collaborate to co-fund a single-center observational study of seizure types in rare genetic epilepsies

NPR Stateside Podcast: One family's fight to find a cure for daughter's rare genetic disorder

Glowing reviews for STXBP1-Related Disorders Research

The STXBP1 Foundation and Children’s Hospital of Philadelphia Announce Phase 2 of the STARR Study for Clinical Trial Readiness, and Clinic Expansion
